Strength
5; 2.5; 1000 mg/1; mg/1; mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597039523
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA212614On Market Since
4/23/2020
Pharmacological Classes
Biguanide
Biguanides
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors
Sodium-Glucose Cotransporter 2 Inhibitor
Sodium-Glucose Transporter 2 Inhibitors
Related Drugs
Same classification
RIOMET 500 MG/5 ML SOLUTION
Brand
10631020602•Sun Pharmaceutical Industries Inc.
$1.3551
per ML
RIOMET 500 MG/5 ML SOLUTION
Brand
10631023802•Sun Pharmaceutical Industries Inc.
$1.3551
per ML
ZITUVIMET XR 50-1,000 MG TABLET
Brand
70710180506•Zydus Pharmaceuticals (USA) Inc.
$5.0263
per EA
ZITUVIMET 50-1,000 MG TABLET
Brand
70710178706•Zydus Pharmaceuticals (USA) Inc.
$5.0308
per EA
ZITUVIMET 50-500 MG TABLET
Brand
70710178606•Zydus Pharmaceuticals (USA) Inc.
$5.0779
per EA
JANUMET XR 50-1,000 MG TABLET
Brand
00006008061•Merck Sharp & Dohme LLC
$5.2761
per EA
JANUMET XR 50-1,000 MG TABLET
Brand
00006008062•Merck Sharp & Dohme LLC
$5.2761
per EA
JANUMET XR 50-1,000 MG TABLET
Brand
00006008082•Merck Sharp & Dohme LLC
$5.2761
per EA
JANUMET 50-1,000 MG TABLET
Brand
00006057761•Merck Sharp & Dohme LLC
$5.2792
per EA
JANUMET 50-1,000 MG TABLET
Brand
00006057762•Merck Sharp & Dohme LLC
$5.2792
per EA